Peptide record

TPDB05636

Arg8 cyclo R8 L-R8 l-R8-C6-NP L-R8-INS-NP Mn1-R9 octa-arginine octa-arginine (R8) Octa-arginine(R8) octaarginine (R8) R8-lip R9-GFP CR8 P4 PTD8 R8 Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides standard
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05636
Arg8 cyclo R8 L-R8 l-R8-C6-NP L-R8-INS-NP Mn1-R9 octa-arginine octa-arginine (R8) Octa-arginine(R8) octaarginine (R8) R8-lip R9-GFP CR8 P4 PTD8 R8
Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Anti-infective peptides Cancer-related peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia BBPpredict CellPPD CellPPD-MOD CPPsite3.0 PerseuCPP TumorHoPe2.0
standard
No
A 8-aa standard natural multi-activity (Antibacterial, Antiviral, Blood-Brain Barrier, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
RRRRRRRR
Physicochemical Analysis
C48H98N32O9
ANDCEQGHILKMFPSTWYV
R
1267.52
13.25
8
0
0
+8
6.48
-4.500
0.00
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
8
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 8 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
8
C48H98N32O9
1267.52
13.25
+8
6.48
-4.500
Free
L
Cationic Amphipathic Cationic and hydrophobic
Linear Cyclic
Free
N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O N[C@@H](CC1=NC=NC1)C(=O)O N[C@@H](Cc1ccccc1)C(=O)/N=C/C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)O NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O NCC(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)O N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)/N=C/C(=O)N[C@@H](C(C)C)C(=O)O NCC(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=CN=C(C)/C/1=C\C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)O N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)O
Evidence Records 37 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Assay & Model

Synechocystis sp. PCC 6803, Synechococcus elongatus PCC 7942
Synechocystis sp. PCC 6803, Synechococcus elongatus PCC 7942

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Cationic
Synthetic
Protein (eGFP)
Cytoplasm
Endocytosis (Macropinocytosis)
In vivo
CCCCCCCC
Evidence 2 Activity

Activity

Cell-penetrating Peptides

Target

293T and HeLa

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Amphipathic
Synthetic
Nucleic acid (Plasmid DNA)
Nucleus
Endocytic pathway
In vitro
CCCCCCCC
Evidence 3 Activity

Activity

Cell-penetrating Peptides

Target

Bone marrow dendritic cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Nanoparticle (Liposomes)
Cytosol
R8-Lip resulted in a drastic enhancement in the cross-presentation of the OVA antigen compared to K8-Lip
In vitro
CCCCCCCC
Evidence 4 Activity

Activity

Cell-penetrating Peptides

Target

HeLa cells

Assay & Model

Female Kunming (KM) mice
Female Kunming (KM) mice

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Fluorophore (FITC)
Vesicles
In vitro and in vivo
CCCCCCCC
Evidence 5 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2 cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Nanoparticle (Couramin-6 loaded nanoparticle)
In vitro
CCCCCCCC
Evidence 6 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2 cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Nanoparticle (Insulin loaded nanoparticle)
In vitro
CCCCCCCC
Evidence 7 Activity

Activity

Cell-penetrating Peptides

Target

HUVEC and A549 cells

Assay & Model

A549 xenografts bearing mice and U87 xenografts bearing mice
A549 xenografts bearing mice and U87 xenografts bearing mice

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Nanoparticle (PEG-PCL)
In vitro and in vivo
CCCCCCCC
Evidence 8 Activity

Activity

Cell-penetrating Peptides

Target

Rat Primary Cortical Cultures

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Heparan sulfate receptor-mediated endocytic pathway
In vitro
CCCCCCCC
Evidence 9 Activity

Activity

Cell-penetrating Peptides

Target

Intestinal Loops Of Sprague Dawley Rats

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L
Synthetic
Insulin
L- and D-PenetraMax show greatest increase in ileum insulin absorption than other CPP
In Situ
CCCCCCCC
Evidence 10 Activity

Activity

Cell-penetrating Peptides

Target

HeLa Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
FITC-labeled
Cytosol, Nucleus and Endosomes
Show considerably lower uptake
In vitro
CCGGGTSCC
Evidence 11 Activity

Activity

Cell-penetrating Peptides

Target

S. Aureus Infected Mac-T Or Hbmec Cell Lines , Ex Vivo Calvaria (Skull Cap)

Assay & Model

Femur injury model (Wistar rats (5 to 6 wks of age))
Femur injury model (Wistar rats (5 to 6 wks of age))

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Lysostaphin and LysK
In vitro and in vivo
CCSSCGGGHHHHSCCC
Evidence 12 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2 Cells

Assay & Model

Male Ddy mice weighing 30-40 g Ex-vivo ileum closed loop of Sprague Dawley rats weighing 180–220 g
Male Ddy mice weighing 30-40 g Ex-vivo ileum closed loop of Sprague Dawley rats weighing 180–220 g

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Insulin
In vitro and in vivo
C
Evidence 13 Activity

Activity

Cell-penetrating Peptides

Target

Human Mesenchymal Stem Cells (Mscs) Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L
Synthetic
Fluorescent polymer dots (Pdots)
Cytoplasm
~3 times higher than the cell brightness labelled with R8-Pdots in MSCs cells
In vitro
CCTTSSCCCCC
Evidence 14 Activity

Activity

Cell-penetrating Peptides

Target

Hek293T And Ct26.Cl25 Cell Lines

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
5-methoxyuridine-modified mCherry mRNA, Enhanced green fluorescence protein (EGFP) mRNA and Ovalbumin (OVA) mRNA
Cytoplasm
Exhibited poor uptake efficiency with 11.6% for Arg8
In vitro
CCCCCSCHHHHHHHHSCC
Evidence 15 Activity

Activity

Cell-penetrating Peptides

Target

HeLa, A549,Caco-2, THP-1, and RAW264.7 cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Salmonella phage selz
Late Endosomes/Lysosomes
In vitro
CCCCSSCSCCGGGCC
Evidence 16 Activity

Activity

Cell-penetrating Peptides

Target

Ht29-Md2 Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic and hydrophobic
Synthetic
Superoxide dismutases mimic (Mn1)
Cell Periphery
(Mn1-R9 < Mn1-MPP < Mn1-RW9 < Mn1) , Mn content accumluated was 0.56 nmol.mg-1.
In vitro
CCHHHHHHHTTC
Evidence 17 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2, Hepg2, Hep3B, And Hek 293T Cell Lines

Assay & Model

Balb/c mice (8 weeks old)
Balb/c mice (8 weeks old)

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Cyclic L Cationic
Synthetic
Dnase1 and AR (E35K/A136K)
CR8 conjugation helps Dnase1 penetrate into the rectal mucosa.
In vitro and in vivo
CCTTTCSTTTSCHHHHTTCCC
Evidence 18 Activity

Activity

Cell-penetrating Peptides

Target

Gh4C1 Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Cyclic L Cationic
Synthetic
In vitro
CCCCCCCCC
Evidence 19 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2 Cells And Insulin Reporter Ilite Cells

Assay & Model

12-week-old Male HsdOla:TO mice
12-week-old Male HsdOla:TO mice

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Insulin-GET nanocomplexes (NCs)
transcytosis efficiency of the optimal Insulin-GET NC formulation was ~22-fold greater than the Insulin alone
Energy-dependent transcytosis
In vitro and in vivo
CCCBTTBCGGGCCSCCCCCCCC
Evidence 20 Activity

Activity

Cell-penetrating Peptides

Target

THP-1 Cells Enterococcus Faecalis Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
TAMRA-labelled OP145
Macrophage'S Lysosomes And The Cytosol
At 2h incubation, internalization of OP145-R8 into the macrophages was 77.13%.
In vitro
CCCCCCTTSCCCCCC
Evidence 21 Activity

Activity

Cell-penetrating Peptides

Target

Aspc-1, Bxpc-1, Panc-1 , Aspc-1 And Bxpc-3 Cells

Assay & Model

Female BALB/c nude mice, aged 5–6 weeks with weight of 16–18 g
Female BALB/c nude mice, aged 5–6 weeks with weight of 16–18 g

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
TRAIL protein at c terminal
Cytoplasm And Nuclear Envelope
Found the distribution of TRAIL-Mu3 in the cytoplasm and even in the nuclear envelope of AsPC-1 cell membrane.
In vitro and in vivo
CCTTSSCCCCC
Evidence 22 Activity

Activity

Cell-penetrating Peptides

Target

Nih3T3 And HeLa Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Curcumin
The addition of octaarginine enables curcumin to enter into fibroblasts cells NIH3T3 and HeLa cells. The R8-treated cells show red fluorescence in the PI channel, whereas curcumin-treated cells do not display any signal in the PI channel
Membrane damage
In vitro
CCCSCCCCCCC
Evidence 23 Activity

Activity

Cell-penetrating Peptides

Target

HeLa Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
B1MLM peptide
Cytosol
Fluo4 intensity sharply increased within a few minutes, and it was maintained without the oscillation of cytosolic calcium levels.
In vitro
CCSCCTTGGGGTTTTSCSCCC
Evidence 24 Activity

Activity

Cell-penetrating Peptides

Target

Bbecs Or Rat Astrocytes And Intestine (Caco-2 Assay) And A Bbb Model

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L
Synthetic
carboxyfuorescein (Cf) at N -terminal
Three CPPs (TAT, penetratin and R8) showed the highest internalization profiles in both cell types.
In vitro
CCCSSSTTCCCTTTTC
Evidence 25 Activity

Activity

Cell-penetrating Peptides

Target

Hep G2 And A549 Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Cy3 and FAM-labeled siRNAs
Cytoplasm and nucleus
R8 complexes had moderate cellular uptake.
In vitro
CCSCCCC
Evidence 26 Activity

Activity

Cell-penetrating Peptides

Target

HeLa Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Fluorescent polymer dots (Pdots)
Perinuclear Region (In Cytoplasm)
Fluorescent signals appear on the cell membrane within 5 minutes, while cells incubated with unmodified Pdots show neglectable fluorescence.
Caveolae mediated endocytosis
In vitro
CCCCC
Evidence 27 Activity

Activity

Cell-penetrating Peptides

Target

Human Mesenchymal Stem Cells (Mscs)

Assay & Model

ICR male mice
ICR male mice

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Semiconducting polymer dots (Pdots)
Perinuclear
Pdots coated with R8 showed remarkable endocytic uptake efficiency that was 15 times higher than that of carboxyl Pdots and more than 200 times than that of bare Pdots.
Endocytosis
In vitro and in vivo
CTTTTCCTTTTGGGTCC
Evidence 28 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2 Cell Monolayer

Assay & Model

Male Wistar rats
Male Wistar rats

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Insulin
Transport was in this order: SAR6EW-insulin > R6EW-insulin > R8-insulin > insulin.
Energy dependent pathway route and direct penetration
In vitro and in vivo
CCGGGGGTCCCCCCTTCCCCCCTTSSSCSSCSCC
Evidence 29 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Nanoparticles and FITC labelled dextrans
R8 and Tat increased the uptake of 200-nm nanoparticles by Caco-2 cells to 2.1-3.0 times that was similar or superior than penetratin and PenetraMax
In vitro
CCCSTTCCCCCC
Evidence 30 Activity

Activity

Cell-penetrating Peptides

Target

Caco-2 Cells Bacteroidetes (Bacteroides Vulgatus And Bacteroides Thetaiotaomicron), Firmicutes (Lactobacillus Gasseri, Latilactobacillus Sakei, And Clostridium Bolteae), Actinomicetya (Bifidobacterium Longum, And Bifidobacterium Adolescentis) , Proteobacteria (Escherichia Coli Nissle 1917 And Escherichia Coli K12) And Saccharomyces Boulardii

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L
Synthetic
FITC-dextran
In vitro
CCSHHHHHHHHHHHHTTSCC
Evidence 31 Activity

Activity

Cell-penetrating Peptides

Target

HeLa cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Alexa Fluor 594 and FITC dye
Cytosol
Direct membrane penetration
In vitro
CCCSCSCCCCCC
Evidence 32 Activity

Activity

Cell-penetrating Peptides

Target

LO2 (Human liver cell)

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
In vitro
CCGGGTSCC
Evidence 33 Activity

Activity

Cell-penetrating Peptides

Target

bEnd.3 cells

Assay & Model

Male Sprague-Dawley rats (180–220 g)
Male Sprague-Dawley rats (180–220 g)

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
FD-4 molecule and Insulin
Uptake effect of R8 (both L- and D-forms) was stronger than that of Tat
In vitro and in vivo
CCCSSSTTCCCTTTTC
Evidence 34 Activity

Activity

Cell-penetrating Peptides

Target

MCF7 cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Non-natural residues Linear L
Synthetic
HF488 labelled PNAs with 2-aminopyridine (M)
Cytoplasm and nucleoli
Strong fluorescence of PNA-Tat and PNA-R8 than PNA-MK3
In vitro
Evidence 35 Activity

Activity

Cell-penetrating Peptides

Target

U87 and GL261 cells

Assay & Model

Balb/c Nude mice (male, 6–8 weeks old, 18.0–20.0 g)
Balb/c Nude mice (male, 6–8 weeks old, 18.0–20.0 g)

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Transferrin co-modified doxorubicin (DOX)-loaded liposomes (Tf-LPs)
Nuclei
Improved cellular efficiency than free DOX and LPs,
In vitro and in vivo
CCGGGTSCC
Evidence 36 Activity

Activity

Cell-penetrating Peptides

Target

HEI-OC1 cells

Assay & Model

Guinea pigs (250–300 g)
Guinea pigs (250–300 g)

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
coumarin-6-loaded PLGA-NPs and P407-PLGA-NPs
LMWP group had stronger fluorescence, followed by penetratin, TAT and R8 groups
In vitro and in vivo
CTTHHHHHHHHHHHHHHHHHHHHHTTHHHHSGGGTTHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTTTSSSSTTCTTTHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
Evidence 37 Activity

Activity

Tumor-homing Peptides

Target

Targeting, Penetrating
Lung cancer
Neuropilin-1

Source & Reference

TumorHoPe2.0
TumorHoPe2
Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy
2014
Gao H et al. Int J Pharm.2015 Jan 15 478(1):240-250

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
HUVEC, A549, U87 (Human Glioma cell line)
4-5 weeks old BALB/c male nude mice
Synthetic
Docetaxel(DTX)
Additional Detail Fields 4 fields
Docetaxel(DTX)
CCCCCCCC CCGGGTSCC CCSSCGGGHHHHSCCC C CCTTSSCCCCC CCCCCSCHHHHHHHHSCC CCCCSSCSCCGGGCC CCHHHHHHHTTC CCTTTCSTTTSCHHHHTTCCC CCCCCCCCC CCCBTTBCGGGCCSCCCCCCCC CCCCCCTTSCCCCCC CCCSCCCCCCC CCSCCTTGGGGTTTTSCSCCC CCCSSSTTCCCTTTTC CCSCCCC CCCCC CTTTTCCTTTTGGGTCC CCGGGGGTCCCCCCTTCCCCCCTTSSSCSSCSCC CCCSTTCCCCCC CCSHHHHHHHHHHHHTTSCC CCCSCSCCCCCC CTTHHHHHHHHHHHHHHHHHHHHHTTHHHHSGGGTTHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTTTSSSSTTCTTTHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
HUVEC, A549, U87 (Human Glioma cell line)
4-5 weeks old BALB/c male nude mice